Literature DB >> 22307442

A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency.

Antonio Pisani1, Bianca Visciano, Roberta Russo, Giusi R Mozzillo, Caterina Porto, Ilaria De Maggio, Roberta Russo, Gianfranco Pontarelli, Guglielmo R D Villani, Bruno Cianciaruso, Paola Di Natale.   

Abstract

Fabry disease is an X-linked lysosomal disease caused by mutations of the alpha-galactosidase A (GLA) gene at chromosome subband Xq22.1. To date, more than 600 genetic mutations have been identified to determine the nature and frequency of the molecular lesions causing the classical and milder variant phenotypes and for precise carrier detection. We report here a Fabry family (mother, son and daughter) where the alpha-galactosidase A defect was associated with a glucose-6-phosphate dehydrogenase (G6PD) deficiency. Mutation analysis revealed for the GLA gene the presence of a new mutation, i.e., a small deletion (c.452delA) on exon 3 and for the G6PD gene the presence of 2 mutations, p.V68M (G6PD Asahi, G6PD A+) and p.N126D (G6PD A+) on exon 3 and exon 4, respectively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307442     DOI: 10.5301/jn.5000073

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  1 in total

1.  The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease.

Authors:  Yuichi Sakamaki; Hiroki Maruyama; Noriyuki Homma; Gen Nakamura; Eiichi Ito; Kunihiko Makino; Kazuhiro Yoshita; Yumi Ito; Yutaka Osawa; Naofumi Imai; Mitsuhiro Ueno; Shigeru Miyazaki; Ichiei Narita
Journal:  CEN Case Rep       Date:  2014-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.